Furthermore, qPCR showed that the mRNA expression of Skp2 and downstream genes, RhoA, was inhibited by treatment of both ER-positive and tamoxifen-resistant breast cancer cells with AC (Fig. 4a-d). This evidence concerns the gene SKP2 and breast carcinoma.